- Home
- CDXC
as 11-21-2024 4:00pm EST
ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.
| Founded: | 1999 | Country: | United States |
| Employees: | N/A | City: | LOS ANGELES |
| Market Cap: | 546.9M | IPO Year: | N/A |
| Target Price: | $8.00 | AVG Volume (30 days): | 3.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.02 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.32 - $7.85 | Next Earning Date: | 10-31-2024 |
| Revenue: | $91,668,000 | Revenue Growth: | 9.95% |
| Revenue Growth (this year): | 18.64% | Revenue Growth (next year): | 20.72% |
Latest ChromaDex Corporation News
CDXC Breaking Stock News: Dive into CDXC Ticker-Specific Updates for Smart Investing
Simply Wall St.
3 days ago
3 US Stocks Estimated To Be Trading At Discounts Ranging From 13% To 41%
Simply Wall St.
7 days ago
3 US Growth Companies With Strong Insider Confidence
Business Wire
8 days ago
ChromaDex’s Patented Nicotinamide Riboside (NR) Ingredient, Niagen®, Featured as the Hero Ingredient in Longevity.Technology’s Inaugural Longevity Supplement
Zacks
13 days ago
What Makes ChromaDex (CDXC) a Strong Momentum Stock: Buy Now?
Zacks
14 days ago
5 Stocks With Recent Price Strength to Tap Wall Street Rally
Business Wire
15 days ago
ChromaDex's Pharmaceutical-Grade Niagen® IV Now Accessible at over 200 Restore Hyper Wellness Clinics Nationwide
Simply Wall St.
15 days ago
Shareholders Can Be Confident That ChromaDex's (NASDAQ:CDXC) Earnings Are High Quality
Zacks
17 days ago
ChromaDex Corporation (CDXC) Hit a 52 Week High, Can the Run Continue?
Compare CDXC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CDXC ChromaDex Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.